Seminars in Reproductive Medicine,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 1, 2023
Abstract
The
female
reproductive
tract
(FRT)
is
home
to
diverse
microbial
communities
that
play
a
pivotal
role
in
health
and
disorders
such
as
infertility,
endometriosis,
cervical
cancer.
To
understand
the
complex
host–microbiota
interactions
within
FRT,
models
authentically
replicate
FRT's
environment,
including
interplay
between
microbiota,
mucus
layer,
immune
system,
hormonal
cycle,
are
key.
Recent
strides
organoid
microfluidic
technologies
propelling
research
this
domain,
offering
insights
into
FRT–microbiota
potential
therapeutic
avenues.
This
review
delves
current
state
of
FRT
microbe
integration
techniques,
evaluating
their
merits
challenges
for
specific
objectives.
Emphasis
placed
on
innovative
approaches
applications,
integrating
organoids
with
microfluidics,
using
patient-derived
biobanks,
offers
deeper
mechanistic
personalized
strategies.
Modeling
various
properties
explored,
from
encompassing
age-related
epithelial
features,
oxygen
levels,
effects
layers,
responses,
interactions,
highlighting
transform
predict
possible
outcomes.
Reproductive Female and Child Health,
Journal Year:
2024,
Volume and Issue:
3(2)
Published: June 1, 2024
Abstract
Background
Bacterial
vaginosis
increases
risk
of
preterm
birth
and
low
birthweight,
adverse
pregnancy
outcomes
that
disproportionately
affect
low‐
middle‐income
countries
(LMICs).
Objectives
We
aimed
to
estimate
the
prevalence
bacterial
among
pregnant
women
attending
antenatal
care
in
LMICs
between
2000
2020.
Search
Strategy
conducted
a
systematic
review
PubMed,
Embase
five
regional
databases.
Selection
Criteria
included
studies
published
2020
which
was
reported
care.
Data
Collection
Analysis
corrected
point
estimates
applied
random‐effects
models
generate
pool
estimates.
carried
out
subgroup
analyses
by
study
year,
country‐income
level,
HIV
prevalence,
sample
size,
diagnostic
method,
trimester
pregnancy,
presence
symptoms
at
diagnosis
bias.
Main
Results
Of
1132
publications,
74
met
inclusion
criteria,
contributing
80
data
points
from
46
661
women.
Overall
pooled
mean
across
15.7%.
Regional
ranged
25.1%
sub‐Saharan
Africa
7.4%
Central
Southern
Asia.
Prevalence
33.4%
where
≥10%,
6.6%
<10%.
The
who
were
symptomatic
24.2%
versus
11.8%
those
without
associated
symptoms.
Conclusions
is
high.
World
Health
Organization
guidelines
recommend
screening
treatment
for
This
recommendation
should
be
extended
include
all
have
infection.
Research
needed
characterise
biological
mechanisms
lead
investigate
interventions
may
better
interrupt
these
pathways.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(10), P. 1979 - 1979
Published: Sept. 30, 2024
Intrapartum
antibiotic
prophylaxis,
considered
able
to
prevent
streptococcal
transmission
from
mother
newborn
and
its
severe
negative
consequences,
leads
microbiota
dysbiosis,
described
as
having
a
impact
on
well-being
in
both
elements
of
the
dyad.
Central African Journal of Public Health,
Journal Year:
2024,
Volume and Issue:
10(6), P. 242 - 256
Published: Nov. 20, 2024
Genital
infections
are
a
real
public
health
problem
in
developed
countries.
They
have
serious
consequences
such
as
ectopic
pregnancy
(EP),
chronic
pelvic
pain,
premature
delivery,
miscarriage,
cervical
cancer
and
even
infertility.
The
objective
of
this
study
was
to
determine
the
epidemiological
microbiological
profile
genital
among
infertile
women
cities
Ngaoundéré
Garoua.
This
descriptive
carried
out
Protestant
regional
hospitals,
well
military
hospitals
serving
Garoua,
over
period
five
months,
from
August
2020
January
2021.
Women
reproductive
age
(15
45
years)
who
met
inclusion
criteria,
gave
their
informed
consent,
had
at
least
one
consultation
gynecology
department
aforementioned
for
infertility
made
up
our
population.
Thus,
included
100
women,
or
50
per
city.
A
pre-tested
questionnaire
employed
get
data
subjects.
Blood
samples
were
taken
chlamydia
testing,
cervical-vaginal
analysis
(PCV+ATB
mycoplasma
testing).
gathered
information.
SphinxPlus.
V5
program
used
analyze
that
collected.
Ninety-six
percent
participated
vaginal
infection.
women's
modal
range
26–35
years
old,
with
mean
29.
Of
54%
housewives,
33%
completed
elementary;
education,
55
monogamous
marriages.
At
65%,
secondary
most
prevalent
type.
5.15
average
length
Abortions
accounted
41%
patients'
histories,
whereas
69%.
When
pH
analyzed,
majority
(69%)
>
4.5.
Chlamydia
trachomatis
(28.41%),
Ureaplasma
urealyticum
(22.63%),
Candidas
albicans
(20.58%),
Gardnerella
vaginalis
(14.40%),
Mycoplasma
hominis
(9.46%),
spp
(1.65%),
Staphylococcus
(1.64%),
Trichomonas
(0.82%),
Neisseria
gonorrhoeae
(0.41%)
analyses
samples.
etiological
identification
infectious
tubal
origin,
which
can
be
avoided
early
intervention,
is
greatly
aided
by
microbiology.
AJOG Global Reports,
Journal Year:
2023,
Volume and Issue:
3(4), P. 100277 - 100277
Published: Oct. 16, 2023
:
Preterm
labor
(PTB)
is
one
of
the
leading
causes
perinatal
death
and
currently
considered
a
syndrome
with
many
causes.
One
most
important
ascending
infection,
derived
from
bacterial
vaginosis
(BV).
Chlorhexidine
(CLX)
has
proven
to
be
effective
against
BV
biofilms
without
affecting
gestation.
We
aimed
evaluate
effectiveness
universal
primary
prevention
strategy
for
PTB
using
intravaginal
CLX
applied
before
16
weeks
(preterm
vaginal
antiseptics,
PLUVA
study).
performed
prospective
observational
study
two
cohorts
pregnant
women
that
were
assigned
either
by
means
(Cum
Laude
CLX®,
digluconate
0,2%)
(N=413),
or
no
treatment
following
usual
hospital
protocol
(N=704).
Primary
outcomes
incidence
spontaneous
below
34
37
weeks,
including
inductions
premature
rupture
membranes
(PRM),
any
indication
termination
pregnancy.
Both
compared
Mann-Whitney
Fisher
tests.
Finally,
multivariable
analysis
odds
ratio
(OR)
was
performed,
adjusting
clinical
parameters,
importance
different
determinants
in
prediction
PTB.
In
pregnancies
treated
chlorhexidine
PTB,
induction
PRM,
pregnancy
respectively
at
weeks:
0%,
0.24%
1.69,
2.90%
3.15%,
while
non-treated
this
9%,
11%,
12%
23%,
35%
43%.
According
analysis,
prior
halved
(OR
0.52,
p<0.05).
Universal
reduces
especially
weeks.
Seminars in Reproductive Medicine,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 1, 2023
Abstract
The
female
reproductive
tract
(FRT)
is
home
to
diverse
microbial
communities
that
play
a
pivotal
role
in
health
and
disorders
such
as
infertility,
endometriosis,
cervical
cancer.
To
understand
the
complex
host–microbiota
interactions
within
FRT,
models
authentically
replicate
FRT's
environment,
including
interplay
between
microbiota,
mucus
layer,
immune
system,
hormonal
cycle,
are
key.
Recent
strides
organoid
microfluidic
technologies
propelling
research
this
domain,
offering
insights
into
FRT–microbiota
potential
therapeutic
avenues.
This
review
delves
current
state
of
FRT
microbe
integration
techniques,
evaluating
their
merits
challenges
for
specific
objectives.
Emphasis
placed
on
innovative
approaches
applications,
integrating
organoids
with
microfluidics,
using
patient-derived
biobanks,
offers
deeper
mechanistic
personalized
strategies.
Modeling
various
properties
explored,
from
encompassing
age-related
epithelial
features,
oxygen
levels,
effects
layers,
responses,
interactions,
highlighting
transform
predict
possible
outcomes.